The effect of nettle extract in diabetes

Not Applicable

• Conditions: Diabetes.; Insulin-dependent diabetes mellitus, Non-insulin-dependent diabetes mellitus; E10-11

• Registration Number: IRCT2013062013727N1
• Lead Sponsor: Vice Chancellor for Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

both genders over the age of 30 years old and common diabetes drugs usage(metformin, glibenclamid).
Exclusion criteria: patients with renal disorder; cardiovascular, liver, infections, thyroid diseases, allergies; use of NSAIDS (non steroid anti inflammatory drugs); use of estrogen and progestron drugs; pregnancy and breastfeeding and participate in other trials.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose level. Timepoint: Before study and 8 weeks after intervention. Method of measurement: Fasting blood glucose concentrations.

Secondary Outcome Measures

Name	Time	Method
DL-cholesterol. Timepoint: Early Intervention and 8 weeks after intervention. Method of measurement: LDL-cholesterol concentratiom.;HDL-cholesterol. Timepoint: Early Intervention and 8 weeks after intervention. Method of measurement: HDL-cholesterol concentration.;Triglyceride. Timepoint: Early Intervention and 8 weeks after intervention. Method of measurement: Triglyceride concentration.;Cholesterol. Timepoint: Early Intervention and 8 weeks after intervention. Method of measurement: Cholesterol concentration.;Blood insulin. Timepoint: Early Intervention and 8 weeks after intervention. Method of measurement: Insulin concentration.